Global Incidence Rate of Rheumatoid Arthritis Increased From 1990 to 2021

Follow Drugslib on

Medically reviewed by Carmen Pope, BPharm. Last updated on June 16, 2025.

By Elana Gotkine HealthDay Reporter

MONDAY, June 16, 2025 -- The incidence rate of rheumatoid arthritis (RA) increased globally from 1990 to 2021, with the heaviest burden born by regions with a high sociodemographic index (SDI), according to a study published online June 16 in the Annals of the Rheumatic Diseases.

Wenyi Jin, M.D., from the Renmin Hospital of Wuhan University in China, and colleagues examined the burden of RA across 953 locations worldwide to assess socioeconomic-driven distributions and inequalities in burden. To forecast long-term burdens with scenario simulations, a deep-learning pipeline was developed.

The researchers found that RA affected 17.9 million people globally in 2021, with an increase of 13.2 percent in the incidence rate from 1990 to 2021, trending younger and broader. From 1980 to 2021, there was a 32.7 percent decrease in the age-standardized death rate, while from 1990 to 2021, global disability-adjusted life years (DALYs) nearly doubled. The heaviest burden was born by regions with a high SDI; from 1990 to 2021, regional inequalities aggregated. Declining trends were uniquely seen in Japan (1990 to 2021), exemplified by a 22.4 percent decrease in Tokyo's age-standardized DALY rate since 1990, unlike that in other high SDI regions. Among male patients in high-smoking regions like China, implementing smoking control policies is forecasted to reduce RA-related deaths by 16.8 percent and DALYs by 20.6 percent.

"Japan's sustained decline in DALYs despite a high SDI proves that socioeconomic status alone doesn't dictate outcomes; proactive health care policies such as early diagnosis programs can reverse trends," co-lead author Baozhen Huang, Ph.D., from the City University of Hong Kong, said in a statement.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2025-06-17 06:13

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords